Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1985
[Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia]K Sampi, Y Kaneko, N Maseki, et al.
Surgical Neurology|December 1, 1982
A suprasellar embryonal carcinoma producing alpha-fetoprotein and human chorionic gonadotropin; treated with combined chemotherapy followed by radiotherapyN Ono, F Takeda, J Uki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1987
[Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients]K Sampi, R Kumai, N Maseki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 1, 1989
[Follicular lymphoma in Japan: retrospective study on natural history and therapeutic results in 50 cases collected from 4 institutions]T Takagi, K Sampi, U Sawada, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Combination of pipemidic acid, colistin sodium methanesulfonate and nystatin may be less effective than nystatin alone for prevention of infection during chemotherapy-induced granulocytopenia in acute leukemiaK Sampi, M Sakurai, R Kumai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1989
[High-dose cytosine arabinoside treatment of leukemia with special reference to the optimal number of doses]K Sampi, N Maseki, R Kumai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 9, 1999
[Early phase II study of KRN8602 (MX2), a novel anthracycline derivative for acute leukemia]Y Takemoto, K Sampi, Y Kuraishi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 30, 1998
[Phase II study of KRN8602 (MX2) for malignant lymphoma]K Okabe, K Sampi, Y Kuraishi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1991
[An 8; 21 chromosome translocation associated leukemia presenting with large intestinal granulocytic sarcoma: a report of two cases]T Matsunaga, N Maseki, Y Kaneko, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 13, 1999
[Pilot late phase II study of KRN8602 (MX2), a novel anthracycline derivative, for acute leukemia--a dose finding study in combination]A Hiraoka, K Sampi, Y Kuraishi, et al.
Pageof 8